Free Design Audit Available - Click Here for Details


Omini receives patent approval for OECT based device

Omini, a medtech company developing the first multiplexed blood testing platform for personalised medicine and chronic disease management, has been given approval by European authorities of a patent for its multi-gate Organic Electro-Chemical Transistor (OECT)-based detection device comprising depolarisation electrode.

Read More »